Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease.
Saved in:
| Title: | Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease. |
|---|---|
| Authors: | Rogers MA; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Bartoli-Leonard F; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Zheng KH; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Department of Vascular Medicine, Academic Medical Center, Amsterdam UMC, the Netherlands (K.H.Z., E.S.G.S.)., Small AM; Department of Medicine (A.M.S., C.J.O.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Boston VA Healthcare System, MA (A.M.S., P.N., C.J.O.)., Chen HY; Department of Medicine, McGill University, Montreal, Quebec, Canada (H.Y.C., J.C.E., G.T.)., Clift CL; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Asano T; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Kuraoka S; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Blaser MC; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Perez KA; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Natarajan P; Boston VA Healthcare System, MA (A.M.S., P.N., C.J.O.).; Cardiology Division, Department of Medicine, Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston (P.N.)., Yeang C; Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, Department of Medicine, University of California, La Jolla, San Diego (C.Y., S.T.)., Stroes ESG; Department of Vascular Medicine, Academic Medical Center, Amsterdam UMC, the Netherlands (K.H.Z., E.S.G.S.)., Tsimikas S; Division of Cardiovascular Diseases, Sulpizio Cardiovascular Center, Department of Medicine, University of California, La Jolla, San Diego (C.Y., S.T.)., Engert JC; Department of Medicine, McGill University, Montreal, Quebec, Canada (H.Y.C., J.C.E., G.T.)., Thanassoulis G; Department of Medicine, McGill University, Montreal, Quebec, Canada (H.Y.C., J.C.E., G.T.)., O'Donnell CJ; Department of Medicine (A.M.S., C.J.O.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Boston VA Healthcare System, MA (A.M.S., P.N., C.J.O.)., Aikawa M; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Center for Excellence in Vascular Biology (M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Singh SA; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Aikawa E; Center for Interdisciplinary Cardiovascular Sciences (M.A.R., F.B.-L., K.H.Z., C.L.C., T.A., S.K., M.C.B., K.A.P., M.A., S.A.S., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Center for Excellence in Vascular Biology (M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA. |
| Source: | Circulation [Circulation] 2024 Jan 30; Vol. 149 (5), pp. 391-401. Date of Electronic Publication: 2023 Nov 08. |
| Publication Type: | Meta-Analysis; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
